RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Changes in waveform of congenital nystagmus associated with biofeedback treatment.

A study was made of parameters of congenital nystagmus which responded to auditory biofeedback treatment. The parameters studied included foveation time, amplitude, and frequency. The patient's right retina was observed with an infrared television fundus camera, and the fundus image was recorded on video tape. The position of the eye during nystagmus, observed via the fundus camera and recorded on video, was analysed at every 1/60 second intervals. The displacement in degrees between the fixation target, projected on to the retina, and the foveola was measured for each interval. Using biofeedback, the subjects could voluntarily suppress nystagmus and prolong foveation time. A damping of the nystagmus amplitude, intensity, and frequency was observed. On the average the intensity decreased by about 40%, and the foveation time was prolonged by about 190%. After completion of the training all the patients reported a subjective improvement in their vision when suppressing their nystagmus. Possibly biofeedback training acts to reduce the nystagmus and extend foveation time, thereby improving the ability to fixate.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app